Home Visit
Upload
Prothrombin G20210A (Factor II) Mutation
Also known as: Prothrombin G20210A (Factor II) Mutation Detection, EDTA Blood
No special precautions
Sample Type
Blood
Recommended for
Male, Female
Report
Within 24 Hours
Blood test at Home
NABL & CAP Accredited Labs
Accurate & Quality Test Reports
Trusted by Leading Doctors & Hospitals
Overview
The Prothrombin G20210A mutation is found in the FII gene in the body. This mutation affects blood clotting by increasing the levels of prothrombin, a protein involved in forming clots, and increases the risk of developing blood clots. Understanding this mutation helps in assessing the risk of venous thrombosis and informing appropriate treatment decisions. The Prothrombin G20210A (Factor II) Mutation assay is used to detect the G20210A mutation in the FII gene. This mutation is associated with an increased risk of venous thrombosis, which is the formation of blood clots in the veins. The clinical utility of this assay lies in identifying individuals who may be at higher risk for developing venous thrombosis. It is particularly beneficial for individuals with a personal history of venous thrombosis, those with a family history of the condition, and pregnant women or women taking oral contraceptives who have previously experienced a venous thrombotic event. By identifying individuals with this mutation, appropriate preventive measures and management strategies can be implemented to reduce the risk of future thrombotic events.
Prothrombin G20210A (Factor II) Mutation Detection, EDTA Blood Price
Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Prothrombin G20210A (Factor II) Mutation Detection, EDTA Blood with a clear pricing structure.
The Prothrombin G20210A (Factor II) Mutation Detection, EDTA Blood Price in Mumbai is ₹ 5,830 .
We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.
Frequently Asked Questions
This test detects the presence of the Prothrombin G20210A mutation in the FII gene.
This test helps identify individuals at an increased risk of developing blood clots. It is mainly done to • Assess the risk of developing blood clots. • Assess the risk of venous thrombosis. • Inform appropriate preventive measures and treatment plans.
Doctors may recommend this test for • Individuals with a personal or family history of venous thrombosis, • Individuals who are taking oral contraceptives and have experienced a venous thrombotic event. • Pregnant women.
Abnormal results, i.e., reports indicating that the mutation is present, mean that there is an increased risk of developing blood clots. Abnormal results do not necessarily mean you have a clot or a serious condition, but it's important to discuss them with your doctor for further evaluation and appropriate management.
For this test: • A sample of 3-5 ml of your EDTA whole blood will be required. • The collection procedure is quick and simple, involving a blood draw.
To prepare for this test: • No fasting or special diet is needed. • Make sure to inform your doctor about any medications you are taking, as certain drugs can interfere with the test results. • Follow any additional instructions given by your doctor regarding medications or other preparations. Please reach out to your healthcare provider for any specific requirements.
Other tests that may be ordered alongside the Prothrombin G20210A (Factor II) Mutation test include: • Complete Blood Count (CBC): This test evaluates different components of your blood, including red and white blood cells, to assess overall blood health. • Coagulation Panel: This panel includes various tests to evaluate clotting factors and assess the overall functioning of the coagulation system.
FII G20210A Mutation test, Prothrombin Gene Mutation test
Venous thrombosis refers to the formation of blood clots in the veins, usually in the legs or pelvis. It can cause pain, swelling, and potentially serious complications if the clot dislodges and travels to other parts of the body.
Ratings & Reviews (0)
Why Metropolis?
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.
WhatsApp